Caplin Point Laboratories Limited (CAPLIPOINT.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 114.38B |
| Enterprise Value | 108.22B |
| P/E Ratio | 30.63 |
| PEG Ratio | 1.57 |
| Price/Sales Ratio | 8.98 |
| Price/Book Ratio | 5.48 |
| Enterprise/Revenue | 8.7 |
| Enterprise/EBITDA | 22.29 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.29 |
| Operating Margin | 0.36 |
AD
Management Effectiveness
| Return On Assets | 0.16 |
| Return On Equity | 0.2 |
Income Statement
| Revenue | 21.87B |
| Revenue/Share | 287.75 |
| Gross Profit | 10.5B |
| EBITDA | 8.76B |
| Net Income | 6.41B |
| Diluted EPS | 84.11 |
Balance Sheet
| Total Cash | 10.07B |
| Total Cash/Share | 132.45 |
| Total Debt | 46.1M |
| Total Debt/Equity | 0 |
| Current Ratio | 6.7 |
| Book Value Per Share | 477.67 |
Price History
| 52-Week Change | 27.08 |
| 52-Week High | 2,689 |
| 52-Week Low | 1,500.3 |
| Moving Average 50 Days | 2,210.61 |
| Moving Average 200 Days | 1,916.82 |
Statistics
| Average Volume | 193,461 |
| Shares Outstanding | 76.01M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 7 |
| Trailing Annual Dividend Yield | 0.27 |
| Payout Ratio | 0.07 |
| Last Split Factor | 5:1 |
| Last Split Date | October 19, 2016 |
AD
